Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ITOC 2022 | The use of RNA vaccines to promote CAR-T stimulation in solid tumors

Sebastian Kobold, MD, PhD, Ludwig-Maximilians-Universität München, Munich, Germany discusses the utilization of RNA vaccines to overcome the challenges associated with CAR-T cells in solid tumors. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.